GLP-1R, GIPR, GCGR Program(Septerna)

N/A

Report date: 2024/11/07 17:25:58

NME

Base Information

Drug NameGLP-1R, GIPR, GCGR Program(Septerna)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlucagon-like peptide 1 receptor modulatorsGlucose-Dependent Insulinotropic Polypeptide Receptor modulatorsGlucagon receptor modulators

TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon receptor

Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Metabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSepterna Inc

China Registration ClassN/A

Develop Information

Active CompaniesSepterna Inc

Inactive CompaniesN/A

Active IndicationsObesityDiabetes Mellitus, Type 2Metabolic Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A